.After antibody-drug conjugate (ADC) expert Seagen was actually sold to Pfizer in 2014 for an immens...
.On the heels of a stage 3 succeed that failed to blow away financiers, Ironwood Pharmaceuticals is ...
.Do not quit Monte Rosa Therapies now. The Boston-based biotech is actually enjoying after authorizi...
.Welcome to today's Chutes & Ladders, our summary of significant management hirings, firings and ...
.Celebrating his company's upsized going public (IPO), Septerna chief executive officer Jeffrey Fine...
.AbbVie has gone back to the source of its antipsychotic goliath Vraylar searching for yet another r...
.GenSight Biologics is actually weeks off of losing loan. Once again. The biotech merely possesses e...
.Monopar Therapies is recuperating a medication coming from the scrap heap of AstraZeneca's uncommon...
.With brand-new data out on Arcus Biosciences' speculative HIF-2a prevention, one group of analysts ...
.After creating a gene therapy partnership with Dyno Rehabs in 2020, Roche is actually back for more...